Clinical targeting recombinant immunotoxins for cancer therapy

Recombinant immunotoxins (RITs) are proteins that contain a toxin fused to an antibody or small molecules and are constructed by the genetic engineering technique. RITs can bind to and be internalized by cells and kill cancerous or non-cancerous cells by inhibiting protein synthesis. A wide variety...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Meng, Liu, Zeng-Shan, Liu, Xi-Lin, Hui, Qi, Lu, Shi-Ying, Qu, Lin-Lin, Li, Yan-Song, Zhou, Yu, Ren, Hong-Lin, Hu, Pan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5530862/
https://www.ncbi.nlm.nih.gov/pubmed/28790855
http://dx.doi.org/10.2147/OTT.S134584

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5530862/
https://www.ncbi.nlm.nih.gov/pubmed/28790855
http://dx.doi.org/10.2147/OTT.S134584

Ejemplares similares